ArticleAsian Pacific journal of cancer prevention : APJCP2026
In Silico Identification of Hydroxyxanthone Derivatives as CDK2/EGFR Dual Inhibitor for Colorectal Cancer Treatment.
Faris Hermawan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.